TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve”) (TSXV: EVE) is pleased to announce that it has been included in the Horizons Marijuana Life Sciences exchange-traded fund (TSX: HMMJ). To be eligible for inclusion in this ETF, issuers must meet certain minimum asset, market capitalization and liquidity thresholds. “Eve is pleased to be included in the Horizons Marijuana Life Sciences ETF. Eve has achieved successes and made strides in production, expansions, branding and, with the addition of sales and extracts authorizations, licensing and we hope that the inclusion in this ETF will enable us to reach additional shareholders who may share our direction,” said Melinda Rombouts, CEO of Eve. ABOUT EVE & CO INCORPORATED Eve, through its wholly owned subsidiary Natural MedCo Ltd., is a licensed producer and seller of dried cannabis and cannabis plants, and producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. Natural MedCo Ltd. is Canada’s first female founded licensed producer, and received its cultivation license from Health Canada in 2016 and its sales license from Health Canada in June 2018. Eve is led by a team of agricultural experts and has a 220,000 sq. ft. scalable greenhouse production facility located in Middlesex County, Ontario with 32 acres of adjacent land for future expansion. Eve has broken ground on an additional 780,000 sq. ft. expansion, bringing Eve’s total anticipated greenhouse capacity to 1,000,000 sq. ft. The TSX Venture Exchange (the “TSXV”) has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s filing statement dated June 18, 2018 and available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law. For further information, please contact: Melinda Rombouts President and Chief Executive Officer Eve & Co Incorporated Telephone: (855) 628-6337 Shobana Thaya Investor Relations Telephone: (416) 807-1009
Eve & Co Included in Horizons Marijuana Life Sciences ETF
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...